chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Influenza like illness, Pyrexia
Clinical narrative: Flu-like symptoms; high fever (102 F); headache; chills; This is a spontaneous report from a non-contactable consumer (patient). A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EP6955), via an unspecified route of administration in left arm on 27Mar2021 13:15 (at the age of 60-years-old) as dose 2, single for COVID-19 immunization. Medical history included hypertension (moderate hypertension (well controlled)). The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6208), via an unspecified route of administration in left arm on 06Mar2021 01:15 a.m. (at the age of 60-years-old) as dose 1, single for COVID-19 immunization and experienced Fever and Vaccination site pain. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not having any known allergies. The patient experienced flu-like symptoms, high fever (102 F), headache and chills on 28Mar2021 03:00. Since the vaccination, patient has not been tested for COVID-19. The patient received treatment with ibuprofen 400 mg. Outcome of events was resolving.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Lethargy, Pyrexia
Clinical narrative: fever; lethargy; This is a spontaneous report from a contactable other Healthcare professional (patient). A 28-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6200) via intramuscular routed on 21Feb2021 at 07:40 as Dose 2, Single for COVID-19 immunization. Vaccination facility type was reported as Hospital. The patient's medical history was reporter as none. The patient's concomitant medications were not reported. The patient was not received any other vaccine prior vaccination with Pfizer vaccine. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9465) via intramuscularly administered on Left arm (shoulder) on 30Jan2021 at 07:40 as Dose 1, Single for COVID-19 immunization. On 30Jan2021 at 16:00 (after first dose of vaccination), the patient had experienced arm soreness on left arm for about 3 days. The patient experienced fever on 22Feb2021 at 13:00 and lethargy lasting about 4 hours only about 29 hours after the vaccine was given. Returned to normal afterwards with no known lasting effects. No relevant lab tests was reported. The patient had received Tylenol every 6hrs as treatment medication for fever. The outcome of the events was recovered on and unknown date in 2021. The reporter consider events fever as non-serious. The reporter considered BNT162B2 had a causal effect to the adverse events.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain, Pyrexia
Clinical narrative: This is a spontaneous report from a Pfizer-sponsored program, by a contactable female consumer (patient). A female patient, of unspecified age, received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection), via an unspecified route on Mar 19, 2021, single dose for COVID-19 immunization. The patient's medical history and concomitant medications not reported. On an unknown date, patient experienced headache, fever, chills, body aches and nausea. She asked if this was normal. It told to her 'yes' some people experience this. The outcome of the events: unknown. No follow up attempts possible. Information about batch/lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: Fever; fatigue; body aches; This is a spontaneous report from a contactable physician via Pfizer Sales Representative (patient). This Physician (Patient) reported similar events for 2 patients (Herself and Husband). This female Physician reported for herself. A female patient of an unspecified age received dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fever, fatigue, body aches. It was further reported that She reported that both she and her husband both experienced side effects after receiving each shot. Symptoms included. Fever, fatigue and body aches. Symptoms was appeared after 1/2 of getting the shot and lasted a day and the event took place after use of product. The clinical outcome for all the events was reported as recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021338743 same reporter/product/event, different patient
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: Fever; fatigue; body aches; This is a spontaneous report from a contactable other hcp (Husband) via Pfizer sales representative. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number and Expiration date was not reported), first dose via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fever, fatigue, body aches on an unspecified date. Patient experienced side effects after receiving shot. Symptoms included fever, fatigue, and body aches. Symptoms appeared after 1/2 of getting the shot and lasted a day. Clinical outcome of events was recovered on unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021338631 same reporter/product/event, different patient
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vaccination site erythema, Vaccination site swelling
Clinical narrative: swollen under armpit; swollen and red injection site; swollen and red injection site; This is a spontaneous report from a contactable consumer (patient).  A 25-year-old female patient received BNT162b2(PFIZER- BIONTECH COVID-19 mRNA VACCINE, Lot number: not reported), via an unspecified route of administration in the left arm on 21Mar2021 at 08:30 (at the age of 25-years-old) as dose number unknown, single  for COVID-19 immunisation.  The patient medical history was not reported. Concomitant medication(s) included sertraline hydrochloride (ZOLOFT). Prior to vaccination, the patient was not pregnant, not diagnosed with COVID-19, did not receive any other vaccines within 4 weeks. Since the vaccination, has the patient has not been tested for COVID-19. On an unknown date, the patient experienced swollen under armpit and swollen and red injection site. No therapeutic measures were taken for the adverse events. The clinical outcome of the events swollen under armpit and swollen, and red injection site was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Pain, Pyrexia
Clinical narrative: low grade fever of 99.3; aches; This is a spontaneous report from a contactable consumer reported for himself. A 43-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL3248; Expiration date was not reported), second dose via an unspecified route of administration, administered in arm right on 23Mar2021 08:00 (at the age of 43-years) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL3248) in right arm on 03Mar2021 08:00 (at the age of 43-years-old) for covid-19 immunisation. No other vaccine in four weeks. No covid prior vaccination. Covid was not tested post vaccination. Approximately 14 hours after second dose, the patient experienced low grade fever of 99.3 along with aches on 24Mar2021 00:30 hr. Lasted about 4 hours. Went away on the day of this report (reported as today). The patient underwent lab tests and procedures which included body temperature: 99.3 on 23Mar2021. AE resulted in none of the above (unspecified details). No treatment was received. Clinical outcome of events was recovered on 24Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Influenza like illness, Vaccination failure
Clinical narrative: low grade fever of 99.3; aches; This is a spontaneous report from a contactable consumer reported for himself. A 43-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL3248; Expiration date was not reported), second dose via an unspecified route of administration, administered in arm right on 23Mar2021 08:00 (at the age of 43-years) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL3248) in right arm on 03Mar2021 08:00 (at the age of 43-years-old) for covid-19 immunisation. No other vaccine in four weeks. No covid prior vaccination. Covid was not tested post vaccination. Approximately 14 hours after second dose, the patient experienced low grade fever of 99.3 along with aches on 24Mar2021 00:30 hr. Lasted about 4 hours. Went away on the day of this report (reported as today). The patient underwent lab tests and procedures which included body temperature: 99.3 on 23Mar2021. AE resulted in none of the above (unspecified details). No treatment was received. Clinical outcome of events was recovered on 24Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue
Clinical narrative: Fatigue; painful joints; This is a spontaneous report from a contactable nurse (patient). A non pregnant 76-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9263 and expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 29Jan2021 (at the age of 76-years-old) at dose 1, single for covid-19 immunization. Other medical history included HBP (blood pressure high), osteoporosis, history of pneumonia and valley fever resulting in DOE (dyspnea on exertion). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. Concomitant medications included losartan; amlodipine; ergocalciferol (VIT D); cyanocobalamin (VIT B12); iron and biotin. The patient previously took macrodantin and experienced drug allergy and experienced pyrexia.  The patient experienced fatigue, painful joints in 2021. The outcome of the events was recovered in Feb2021.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021357652 Same reporter/patient, different vaccine dose number and similar event.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain in left arm after first dose; little headache; Slight fever; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 82-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EM9809, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 02Mar2021 at 12:25 pm (age at vaccination was 82 years) as dose 1, single for COVID-19 immunization. The patient's medical history included diabetes diagnosed many years ago and was under control and blood sugar was very low. The patient did not have any family medical history. The patient's concomitant medications were not reported. The patient takes blood pressure and diabetes pills and was taking prior to the vaccine. No additional vaccines were administered on same date of the Pfizer Suspect. The facility where the most recent COVID-19 vaccine was administered was Hospital and not a military facility. On 02Mar2021 at 12:25 pm, the patient experienced little headache/mild headache and around 19:00-20:00 pm, the patient experienced slight fever. On an unspecified date at 13:25, the patient experienced injection site pain in left arm after first dose. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6203, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 23Mar2021 at 12:25 pm (age at vaccination was 82 years) as dose 2, single for COVID-19 immunization and experienced chills and fever, headache with second dose, body aches and injection site pain in left arm. With the first shot, he had no pain in his arm. No Emergency room or Physician's office visit was required. No relevant test was done. The outcome of the event injection site pain in left arm after first dose was unknown. The outcome of the other events was resolving.  No follow up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Limb discomfort, Mobility decreased, Pyrexia
Clinical narrative: Fever; Chills; Headache; her arms felt horrible, she couldn't move it; her arms felt horrible, she couldn't move it; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in Arm Right on an unspecified date as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in Arm Left on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. The patient mentioned she was in a critical situation with the vaccine. She stated on an unspecified date she had fever, chills, headache and her arms felt horrible, she could not move it. She stated she had the vaccine in her right arm but could not move it. She clarified the first dose was in her left arm and the second dose was in her right arm to try and balance it. It was horrible. The outcome of all events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A 37-years-old female patient received second doe of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8727), via an unspecified route of administration, administered in Arm Right on 24Mar2021 10:30 (Age at vaccination: 37-years-old) as single dose for covid-19 immunization. (Vaccination Facility: clinic). Vaccine was not Administered. Medical history included Allergy, Cholesterol, Blood pressure high all from an unknown date and unknown if ongoing. Concomitant medication included levocetirizine (LEVOCETIRIZINE) taken for hypersensitivity from an unspecified start date and ongoing, simvastatin (SIMVASTATIN) taken for blood cholesterol from an unspecified start date and ongoing, lisinopril (LISINOPRIL) taken for hypertension from an unspecified start date and ongoing. Prior vaccination within 4 weeks was reported as none. Historical vaccine included first dose of BNT162B2 (Batch/lot number-EN6202) in the right arm on 03Mar2021 10:30 (Age at vaccination: 37-years-old) as single dose for covid-19 immunization. It was reported that Consumer states she got the second dose and she had a raging fever all day long of 100.7. She noticed the fever this morning on 05Mar2021 06:30AM. She took Tylenol but it has not gone down even with Tylenol. Provides for Tylenol rapid relief gels 500mg, lot number AAA041, expiration Oct2022. Additional vaccines on same day was reported as none. Adverse event was not resulted in Emergency Room or Physician Office visit. The patient underwent lab tests and procedures which included body temperature: 100.7. The outcome for the event was reported as not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: fever; chills; sore arm; This is a spontaneous report from a contactable consumer. A 42-years-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER8727), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation (at the age of 42 years). The patient medical history and concomitant medications were not reported. Patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On an unspecified date patient experienced fever and chills as well as a sore arm after receiving her second dose of the COVID-19 vaccine. Event took place after use of product. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Pain, Pyrexia
Clinical narrative: Fever; chills; aching; sweating; headache; This is a spontaneous report received from a contactable pharmacist via Pfizer sales representative. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as a dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fever, chills, aching, sweating, headache. The reporter clarified that the adverse event took place after Pfizer product use. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Disease recurrence, Pruritus
Clinical narrative: extreme itching on my neck; extreme itching on my neck; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EM9809), via an unspecified route of administration on 06Mar2021 (at the age of 34-year-old), dose 1, single for COVID-19 immunisation. Medical history included depression, asthma, irritable bowel syndrome (IBS), gastrooesophageal reflux disease (GERD), polycystic ovarian syndrome (PCOS), extreme itching on neck (this was how she discovered that she was allergic to other medications) and had allergies to kiwi, pineapple, oranges, bananas, latex, dogs, cats. Concomitant medications included prescribed medications, multi-vitamins, and birth control medications. The patient previously took acetaminophen; ondansetron (ZOFRAN); hydromorphone hydrochloride (DILAUDID); hydrocodone bitartrate paracetamol (NORCO) and had allergy to these medications. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. The vaccine was administered at hospital. On an unspecified date in Mar2021, the patient had extreme itching on her neck. The patient stated that she became concerned because this was how she discovered that she was allergic to other medications. The patient spoke with the emergency room (ER) and then had a telehealth visit with her primary doctor. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was unknown.  No follow-up attempts are possible; No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021347541 same reporter/patient/product, different dose and similar events
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: fever; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient (son).  A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications. The patient experienced fever on an unspecified. The reporter reported that her son who was fine yesterday but woke up this morning with a little fever. She added his COVID-19 test came back "inconclusive" and they are waiting for the PCR. She said his doctor specified that her son wouldn't have been contagious yesterday, since his symptoms began today. She asked if her mother could get her second dose as scheduled given this potential exposure to COIVD-19date with. She asked if she can be around her son who may have COVID-19, since she has received both doses of the COVID-19 vaccine around 3 weeks ago. The patient underwent lab tests and procedures which included sars-cov-2 test: inconclusive. Outcome of the event was unknown.   No Follow-up attempts are possible: information about lot/batch number cannot be obtained.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; headache; low grade fever; tired; Achy; This is a spontaneous report from a contactable consumer. An 18-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as unknown. Allergies to medications, food, or other products was reported as unknown. It was unknown if the patient had received any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) on an unspecified date as a single dose for COVID-19 immunisation. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had not tested for COVID-19, since the vaccination. On 25Mar2021, the patient had experienced sore arm, headache, low grade fever, tired, and achy. The patient did not receive treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore arm, headache, low grade fever, tired, and achy was resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: added vaccine administration information.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever of 101.8; This is a spontaneous report from a contactable consumer. This consumer (Patient)of unknown age and gender reported that he/she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 24Mar2021 as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unknown date as dose 1, single for COVID-19 immunization. On 25Mar2021, about 24 hours later the patient developed a fever of 101.8. The event outcome was unknown.  No follow-up attempts were possible. information about lot/batch number could not be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain, Pyrexia
Clinical narrative: fever; body aches; nausea; fatigue; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sales Representative. A female patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date, the patient experienced fever, body aches, nausea, fatigue. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: high Fever; This is a spontaneous report from a contactable consumer or other non hcp. A patient of unspecified age and gender received second dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: L3247) via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: unknown) via unspecified route of administration on unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient experienced high fever on an unspecified date. The outcome of the event pyrexia was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (patient). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on 24Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Consumer stated, patient received the first dose of the Pfizer COVID Vaccine yesterday, 24March2021 (later confirmed). And it said you might have as a side effect have a fever on an unknown date. How high a fever should I be concerned about. The outcome of the event was reported as unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 37-year-old (non-pregnant female) patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; solution for injection, batch/lot# EL3247), at the age of 37, via an unspecified route of administration, left arm, on Mar 23, 2021, at 13:15, single dose, for COVID-19 immunization. Patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; solution for injection, batch/lot# EL3247) via an unspecified route of administration, left arm, on Mar 2, 2021, at 13:15, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. The patient did not have any allergies. The patient had no other vaccine within four weeks and no other medications received within 2 weeks of vaccination. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. On Mar 24, 2021, at 12:00, patient experienced chills and body aches. The patient did not receive any treatment. Outcome of the event recovered (at the time of this report). The awareness date: Feb 24, 2021. Follow-up attempts completed. No further information expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Pain in extremity, Pyrexia
Clinical narrative: feeling dizzy; Fever; sore arm; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A 62-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8732), via an unspecified route of administration, administered in Arm Left on 26Mar2021 11:30 (Age at vaccination: 62-years-old) as single dose for covid-19 immunization. Medical history included Esophagitus, allergies to Percocet, Bactrim, Seasonal allergies all from an unknown date and unknown if ongoing. Patient was not diagnosed with covid prior to vaccination. patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. patient did not receive any other medications within 2 weeks of vaccination. The patient concomitant medications were not reported. It was reported that on 26Mar2021 14:00 patient experienced Fever sore arm and feeling dizzy. Patient did not receive any treatment for the events. Patient was not hospitalized for the events. Patient was not tested covid post vaccination. patient underwent lab tests and procedures which included body temperature: fever on 26Mar2021. The outcome for the events was reported as unknown at the time of this report.  Information on Lot/Batch number was available. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: her friend took the vaccine and reported sneezing; This is a spontaneous report from a contactable consumer (patient's friend). This consumer reported two reports. This is second of two reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter reported that her friend took the vaccine and reported sneezing on an unspecified date, the outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021304315 same reporter/drug, different patient/event
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Fatigue, Gastrointestinal injury
Clinical narrative: shortness of breath; congestion and slight cough; chills; sore muscle; fatigue; congestion and slight cough; when I raise my arm above my shoulder a sharp pain strikes down my upper arm from injection site to now; intestinal trauma; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number: EN 6205) via an unspecified route of administration, in left arm, on 08Mar2021 11:45 (at the age of 68-year-old), at dose 1, single for covid-19 immunization. The patient had no medical history. There were no concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 05:30 the patient experienced shortness of breath, congestion and slight cough with some chills, sore muscle, and fatigue. It was also reported that the injection site also caused problems on the 4th day (Mar2021), when he raised the arm above the shoulder a sharp pain strikes down the upper arm from injection site until the time of report. The patient also had intestinal trauma on an unspecified date in 2021, lasted about 6 to 8 days and a little longer with some issues. The events did not result in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nasal congestion, Vaccination site pain
Clinical narrative: shortness of breath; congestion and slight cough; chills; sore muscle; fatigue; congestion and slight cough; when I raise my arm above my shoulder a sharp pain strikes down my upper arm from injection site to now; intestinal trauma; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number: EN 6205) via an unspecified route of administration, in left arm, on 08Mar2021 11:45 (at the age of 68-year-old), at dose 1, single for covid-19 immunization. The patient had no medical history. There were no concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 05:30 the patient experienced shortness of breath, congestion and slight cough with some chills, sore muscle, and fatigue. It was also reported that the injection site also caused problems on the 4th day (Mar2021), when he raised the arm above the shoulder a sharp pain strikes down the upper arm from injection site until the time of report. The patient also had intestinal trauma on an unspecified date in 2021, lasted about 6 to 8 days and a little longer with some issues. The events did not result in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Exophthalmos, Fatigue, Headache, Strabismus
Clinical narrative: Horrible itching at the vaccine site; Horrible itching at the vaccine site with swelling that has not gone away and redness with a rash; Horrible itching at the vaccine site with swelling that has not gone away and redness with a rash; Horrible itching at the vaccine site with swelling that has not gone away and redness with a rash; Eye bludging; Cross eye; Chest pain; Headache; Extremely exhausted.; This is a spontaneous report from a contactable consumer (patient). A 37-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6202; Expiration date was not reported) on the left arm on 23Mar2021 (16:15) (age at vaccination: 37 years) as dose 1, single, with route of administration unspecified, for COVID-19 immunization at the hospital; and medroxyprogesterone acetate (DEPO-PROVERA, Lot number and expiration date were not reported) on the right arm on 23Mar2021 as dose 1, single, with route of administration unspecified, for sickle cell anaemia. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Prior to and since the vaccination, the patient was not diagnosed with COVID-19. Medical history included sickle cell anaemia (taking hydroxycarbamide and medroxyprogesterone acetate); and was allergic to IV contrast, pineapples, green apples, kiwi and adhesives. Concomitant medication included hydroxycarbamide (HYDROXYUREA MEDAC) for sickle cell anaemia. The patient previously took morphine, and had hypersensitivity. On 23Mar2021 (16:30), the patient had a cross eye; eye was "bludging"; chest pain; headache; and was extremely exhausted. On 01Apr2021 (03:00), the patient woke up at 3 AM with horrible itching at the vaccine site with swelling that had not gone away and redness with a rash. The itching continued through the day. The patient did not receive treatment for the reported events. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Horrible itching at the vaccine site; Horrible itching at the vaccine site with swelling that has not gone away and redness with a rash; Horrible itching at the vaccine site with swelling that has not gone away and redness with a rash; Horrible itching at the vaccine site with swelling that has not gone away and redness with a rash; Eye bludging; Cross eye; Chest pain; Headache; Extremely exhausted.; This is a spontaneous report from a contactable consumer (patient). A 37-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6202; Expiration date was not reported) on the left arm on 23Mar2021 (16:15) (age at vaccination: 37 years) as dose 1, single, with route of administration unspecified, for COVID-19 immunization at the hospital; and medroxyprogesterone acetate (DEPO-PROVERA, Lot number and expiration date were not reported) on the right arm on 23Mar2021 as dose 1, single, with route of administration unspecified, for sickle cell anaemia. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Prior to and since the vaccination, the patient was not diagnosed with COVID-19. Medical history included sickle cell anaemia (taking hydroxycarbamide and medroxyprogesterone acetate); and was allergic to IV contrast, pineapples, green apples, kiwi and adhesives. Concomitant medication included hydroxycarbamide (HYDROXYUREA MEDAC) for sickle cell anaemia. The patient previously took morphine, and had hypersensitivity. On 23Mar2021 (16:30), the patient had a cross eye; eye was "bludging"; chest pain; headache; and was extremely exhausted. On 01Apr2021 (03:00), the patient woke up at 3 AM with horrible itching at the vaccine site with swelling that had not gone away and redness with a rash. The itching continued through the day. The patient did not receive treatment for the reported events. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Vaccination site pain
Clinical narrative: Lost his taste and smell; Lost his taste and smell; Vaccinated arm was sore after receiving the vaccine; This is a spontaneous report from a contactable consumer (patient). A 21-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 31Mar2021 as dose 1, single for COVID-19 immunization (at the age of 21-years-old). Medical history included nasal congestion, runny nose and allergy from Mar2021 to an unknown date. The patient's concomitant medications were not reported. The patient stated that, yesterday (31Mar2021) he got his first dose of COVID but he had been having a congested runny nose and he thought it was allergy, then today the next day (01Apr2021) he lost his taste and smell completely. So he was just worried because he was not sure if that was part of the symptoms or side effects of COVID of the first COVID dose and he was just worried thinking because he had job or work the next day and wanted a make sure that like if he had to call, because he might had it so he had to call off. Patient also added that his vaccinated arm was sore after receiving the vaccine (31Mar2021). He will be getting tested later that day (02Apr2021) for COVID-19. It was also reported that he had been having a congested nose for 2 weeks then (by 02Apr2021). That day (02Apr2021), his taste and smell came back. He said the congested nose was not as bad as the previous days. The patient did not receive any treatment, patient was just resting his body. The clinical outcome for the events was recovered on 02Apr2021 except unknown for vaccinated arm was sore after receiving the vaccine.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 72.0
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Fatigue, Headache, Pain
Clinical narrative: Fever of 100-100.4; tired; headache; achey; loss of appetite; This is a spontaneous report from a non-contactable consumer (patient) in response to non-HCP letter sent in cross-reference case. A 72-years-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: SN6205, patient was 72-yeear-oldat the time of vaccination), via intramuscular route of administration, administered in Arm Left on 03Mar2021 at 09:30 as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included migraine and Hashimoto. Concomitant medication(s) included diclofenac (DICLOFENAC) taken for migraine from an unspecified start date and ongoing 2 days prior; levothyroxine sodium (SYNTHROID) taken for autoimmune thyroiditis from an unspecified start date and ongoing; liothyronine sodium (CYTOMEL) taken for autoimmune thyroiditis from an unspecified start date and ongoing. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EL9624), via intramuscular route of administration, administered in Arm Left on 10Feb2021 at 08:22 AM as DOSE 1, SINGLE for covid-19 immunisation and experienced hot/cold, achy, tired, headache, fever all on 11Feb2021 for 4 days with outcomes of events were recovered without any treatment. No prior Vaccinations received. On 03Mar2021, the patient experienced fever of 100-100.4, tired, headache, achey, loss of appetite for 5 days (Outcome unknown for events). The patient underwent lab tests and procedures which included body temperature: 100 - 100.4 on 03Mar2021, sars-cov-2 test: negative on 05Mar2021. No treatment received for Fever and required urgent care on 05Mar2021. The outcome of event (fever of 100-100.4) was recovered on an unspecified date in 2021 and the outcomes of events (tired, headache, achey, loss of appetite) were unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 72.0
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever of 100-100.4; tired; headache; achey; loss of appetite; This is a spontaneous report from a non-contactable consumer (patient) in response to non-HCP letter sent in cross-reference case. A 72-years-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: SN6205, patient was 72-yeear-oldat the time of vaccination), via intramuscular route of administration, administered in Arm Left on 03Mar2021 at 09:30 as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included migraine and Hashimoto. Concomitant medication(s) included diclofenac (DICLOFENAC) taken for migraine from an unspecified start date and ongoing 2 days prior; levothyroxine sodium (SYNTHROID) taken for autoimmune thyroiditis from an unspecified start date and ongoing; liothyronine sodium (CYTOMEL) taken for autoimmune thyroiditis from an unspecified start date and ongoing. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EL9624), via intramuscular route of administration, administered in Arm Left on 10Feb2021 at 08:22 AM as DOSE 1, SINGLE for covid-19 immunisation and experienced hot/cold, achy, tired, headache, fever all on 11Feb2021 for 4 days with outcomes of events were recovered without any treatment. No prior Vaccinations received. On 03Mar2021, the patient experienced fever of 100-100.4, tired, headache, achey, loss of appetite for 5 days (Outcome unknown for events). The patient underwent lab tests and procedures which included body temperature: 100 - 100.4 on 03Mar2021, sars-cov-2 test: negative on 05Mar2021. No treatment received for Fever and required urgent care on 05Mar2021. The outcome of event (fever of 100-100.4) was recovered on an unspecified date in 2021 and the outcomes of events (tired, headache, achey, loss of appetite) were unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Somnolence, Swelling
Clinical narrative: fatigue resulting in sleeping 14 hrs+/day for 3 days; fatigue resulting in sleeping 14 hrs+/day for 3 days; muscle and joint pain; muscle and joint pain; Underarm swelling; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9266 and expiration date was not reported), via an unspecified route of administration, administered in Arm Right on 17Feb2021 09:30 (at the age of 72-years-old) at dose 1, single for covid-19 immunization. Medical history included hypothyroidism, high cholesterol, depression and sulfonamide allergy. Concomitant medications included rabeprazole sodium (ACIPHEX); rosuvastatin calcium (CRESTOR); desvenlafaxine; levothyroxine. The patient had allergies to xanax and azithromycin. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Feb2021, the patient experienced underarm swelling and on 25Feb2021, the patient experienced fatigue resulting in sleeping for 14 hours+ per day for three days, muscle and joint pain for several days that appeared day 10 out. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events underarm swelling, fatigue, muscle pain and joint pain was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.